Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis

被引:498
作者
Garnacho-Montero, J [1 ]
Garcia-Garmendia, JL
Barrero-Almodovar, A
Jimenez-Jimenez, FJ
Perez-Paredes, C
Ortiz-Leyba, C
机构
[1] Hosp Univ Virgen Del Rocio, Intens Care Unit, Seville, Spain
[2] Hosp San Juan de Dios del Aljarafe, Seville, Spain
关键词
sepsis; septic shock; bacteremia; community-acquired infection; antibiotics; critical illness;
D O I
10.1097/01.CCM.0000098031.24329.10
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Our primary goal was to evaluate the impact on in-hospital mortality rate of adequate empirical antibiotic therapy, after controlling for confounding variables, in a cohort of patients admitted to the intensive care unit (ICU) with sepsis. The impact of adequate empirical antibiotic therapy on early (<3 days), 28-day, and 60-day mortality rates also was assessed. We determined the risk factors for inadequate empirical antibiotic therapy. Design. Prospective cohort study. Setting. ICU of a tertiary hospital. Patients. All the patients meeting criteria for sepsis at admission to the ICU. Interventions. None. Measurements and Main Results: Four hundred and six patients were included. Microbiological documentation of sepsis was obtained in 67% of the patients. At ICU admission, sepsis was present in 105 patients (25.9%), severe sepsis in 116 (28.6%), and septic shock in 185 (45.6%). By multivariate analysis, predictors of in-hospital mortality were Sepsis-related Organ Failure Assessment (SOFA) score at ICU admission (odds ratio [OR], 1.29; 95% confidence interval [CI], 1.19-1.40), the increase in SOFA score over the first 3 days in the ICU (OR, 1.40; 95% Cl, 1.19-1.65), respiratory failure within the first 24 hrs in the ICU (OR, 3.12; 95% CI, 1.54-6.33), and inadequate empirical antimicrobial therapy in patients with "nonsurgical sepsis" (OR, 8.14; 95% CI, 1.98-33.5), whereas adequate empirical antimicrobial therapy in "surgical sepsis" (OR, 0.37; 95% CI, 0.18-0.77) and urologic sepsis (OR, 0.14; 95% CI, 0.05-0.41) was a protective factor. Regarding early mortality (<3 days), factors associated with fatality were immunosuppression (OR, 4.57; 95% CI, 1.69-13.87), chronic cardiac failure (OR, 9.83; 95% CI, 1.98-48.69) renal failure within the first 24 hrs in the unit (OR, 8.63; 95% CI, 3.31-22.46), and respiratory failure within the first 24 hrs in the ICU (OR, 12.35; 95% CI, 4.50-33.85). Fungal infection (OR, 47.32; 95% CI, 5.56-200.97) and previous antibiotic therapy within the last month (OR, 2.23; 95% CI, 1.1-5.45) were independent variables related to administration of inadequate antibiotic therapy. Conclusions. In patients admitted to the ICU for sepsis, the adequacy of initial empirical antimicrobial treatment is crucial in terms of outcome, although early mortality rate was unaffected by the appropriateness of empirical antibiotic therapy.
引用
收藏
页码:2742 / 2751
页数:10
相关论文
共 45 条
  • [1] Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
    Alberti, C
    Brun-Buisson, C
    Burchardi, H
    Martin, C
    Goodman, S
    Artigas, A
    Sicignano, A
    Palazzo, M
    Moreno, R
    Boulmé, R
    Lepage, E
    Le Gall, JR
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 (02) : 108 - 121
  • [2] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [3] Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing
    Aronin, SI
    Peduzzi, P
    Quagliarello, VJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) : 862 - 869
  • [4] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [5] A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL
    BONE, RC
    BALK, RA
    FEIN, AM
    PERL, TM
    WENZEL, RP
    REINES, HD
    QUENZER, RW
    IBERTI, TJ
    MACINTYRE, N
    SCHEIN, RMH
    TRENHOLME, G
    NIEDERMAN, M
    CHALFIN, D
    ABALOS, A
    OROPELLO, J
    EMPSON, P
    CAMINITII, S
    GREENMAN, R
    BOOTH, F
    PLOUFFE, J
    RUSSELL, J
    GIANAKOPOULOS, G
    IANNINI, P
    HINDES, R
    COBLENS, K
    KOHLER, R
    MARTIN, M
    BERNARD, G
    EDWARDS, J
    CRISLIP, M
    FILLER, S
    NASRAWAY, SA
    SIGEL, PK
    SOTTILE, FD
    MARTIN, DH
    DEBOISBLANC, BP
    CHANDRASEKAR, PH
    BROUGHTON, WA
    MIDDLETON, RM
    SEIBERT, AF
    EMMANUEL, G
    LIE, TH
    ANDERSON, CLV
    PANKEY, GA
    ANDERSON, P
    OLSEN, K
    SANPEDRO, GS
    GRAHAM, D
    GROSSMAN, J
    WELS, PB
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (06) : 994 - 1006
  • [6] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [7] INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS
    BRUNBUISSON, C
    DOYON, F
    CARLET, J
    DELLAMONICA, P
    GOUIN, F
    LEPOUTRE, A
    MERCIER, JC
    OFFENSTADT, G
    REGNIER, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12): : 968 - 974
  • [8] Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals
    BrunBuisson, C
    Doyon, F
    Carlet, J
    Bedock, B
    Annonay, CH
    Valente, E
    Lescale, O
    Misset, B
    Charbonneau, P
    Vergnaud, M
    Cohen, R
    Coloignier, M
    Frances, JL
    Combes, A
    Duval, O
    Dellamonica, P
    Descamps, JM
    Domart, Y
    Galiacy, JL
    Gouin, F
    Guivarch, G
    Hennequin, C
    Krajevitch, A
    Delmas, P
    Holzapfel, L
    Lepeu, G
    Loirat, P
    Thaler, F
    Knani, L
    Mercier, JC
    Mouton, Y
    Libbrecht, E
    Offenstadt, G
    Pinaud, M
    Pinsart, M
    Girou, E
    Portier, H
    Grappin, M
    Rebeix, MT
    Regnier, B
    Gachot, B
    Ricome, JL
    Sollet, JP
    Mentec, H
    Tempelhoff, G
    Beuret, P
    Lepoutre, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 617 - 624
  • [9] Bacteremia due to Acinetobacter baumannii epidemiology, clinical findings, and prognostic features
    Cisneros, JM
    Reyes, MJ
    Pachon, J
    Becerril, B
    Caballero, FJ
    GarciaGarmendia, JL
    Ortiz, C
    Cobacho, AR
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) : 1026 - 1032
  • [10] COHEN J, 1994, INTENS CARE MED, V20, P522, DOI 10.1007/BF01711909